We are live on ! Find out more
APRE icon

Aprea Therapeutics
APRE

39 hedge funds and large institutions have $25.6M invested in Aprea Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.36% less ownership

Funds ownership: 1.54% → 1.18% (-0.36%)

19% less capital invested

Capital invested by funds: $31.4M → $25.6M (-$5.87M)

22% less funds holding

Funds holding: 50 → 39 (-11)

61% less call options, than puts

Call options by funds: $599K | Put options by funds: $1.53M

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
39
Holders Change
-11
Holders Change %
-22%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
12
Reduced
9
Closed
17
Calls
$599K
Puts
$1.53M
Net Calls
-$932K
Net Calls Change
-$914K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$575K
2
JP Morgan Chase
JP Morgan Chase
New York
+$571K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$426K
4
Citadel Advisors
Citadel Advisors
Florida
+$424K
5
Goldman Sachs
Goldman Sachs
New York
+$373K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.79M
2
SG Americas Securities
SG Americas Securities
New York
-$2.92M
3
Voloridge Investment Management
Voloridge Investment Management
Florida
-$743K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$470K
5
Deutsche Bank
Deutsche Bank
Germany
-$461K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
26
Next Financial Group
Texas
$58K -$727 -8 -1%
Bank of America
27
Bank of America
North Carolina
$53K +$21.3K +234 +83%
Simplex Trading
28
Simplex Trading
Illinois
$21K +$14.9K +164 +469%
TRCT
29
Tower Research Capital (TRC)
New York
$18K -$13.1K -144 -44%
Skandinaviska Enskilda Banken (SEB)
30
Skandinaviska Enskilda Banken (SEB)
Sweden
$11K – – –
Federated Hermes
31
Federated Hermes
Pennsylvania
$11K +$1.45K +16 +17%
SWM
32
Sugarloaf Wealth Management
Georgia
$8K – – –
Citigroup
33
Citigroup
New York
$6K -$818 -9 -14%
Osaic Holdings
34
Osaic Holdings
Arizona
$4K – – –
KTC
35
Kistler-Tiffany Companies
Pennsylvania
$3K – – –
PCM
36
Penserra Capital Management
California
$2K +$91 +1 +4%
Macquarie Group
37
Macquarie Group
Australia
$1K – – –
Koshinski Asset Management
38
Koshinski Asset Management
Illinois
$281 +$273 +3 New
SG Americas Securities
39
SG Americas Securities
New York
– -$2.92M -29,920 Closed
Voloridge Investment Management
40
Voloridge Investment Management
Florida
– -$743K -7,608 Closed
Walleye Capital
41
Walleye Capital
New York
– -$483 -4,947 Closed
Deutsche Bank
42
Deutsche Bank
Germany
– -$461K -4,719 Closed
Fidelity International
43
Fidelity International
Bermuda
– -$406K -4,160 Closed
Charles Schwab
44
Charles Schwab
California
– -$246K -2,518 Closed
VF
45
Virtu Financial
New York
– -$201K -2,057 Closed
Millennium Management
46
Millennium Management
New York
– -$162K -1,660 Closed
Walleye Trading
47
Walleye Trading
New York
– -$134K -1,373 Closed
HF
48
HRT Financial
New York
– -$121K -1,245 Closed
E
49
Ergoteles
New York
– -$91K -929 Closed
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$91K -928 Closed
1
2
3

APRE Hedge Fund Activity: Q3 2021 in Review

39 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Aprea Therapeutics (APRE) for Q3 2021, worth a combined $25.6M — down 19% from $31.4M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of APRE and 6 opened new positions — a net loss of 11 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Susquehanna International Group, adding an estimated $575K. The largest seller was Morgan Stanley, cutting an estimated $3.79M.

  • 39 institutional investors held Aprea Therapeutics (APRE) as of Q3 2021, down from 50 in Q2 2021.
  • Funds reported $25.6M of Aprea Therapeutics stock for Q3 2021, down 19% quarter-over-quarter.
  • 6 funds opened new Aprea Therapeutics positions in Q3 2021 and 17 closed out, a net change of -11 holders.
  • The largest Aprea Therapeutics buyer in Q3 2021 was Susquehanna International Group, an estimated $575K added.
  • The largest Aprea Therapeutics seller in Q3 2021 was Morgan Stanley, an estimated $3.79M sold.

Based on aggregated 13F filings for Q3 2021.